Spots Global Cancer Trial Database for sox
Every month we try and update this database with for sox cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Neoadjuvant TACiE in Locally Advanced Gastric Cancer | NCT05346874 | Gastric Cancer | Oxaliplatin Teysuno Transarterial c... | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma | NCT01552980 | Gastric Adenoca... | S-1 and Oxalipl... | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma | NCT05122091 | Gastric Cancer GastroEsophagea... Fruquintinib SOX | Fruquintinib + ... | 18 Years - 75 Years | Guangxi Medical University | |
| PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery | NCT05468138 | MSI-H PD-1 Immunother... Gastric Cancer Adjuvant Therap... | SOX XELOX Observation PD-1 antibody | 18 Years - 75 Years | Fudan University | |
| Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | NCT03636893 | Gastric Cancer Chemotherapy Ef... | FLOT Chemothera... SOX Chemotherap... | 18 Years - 80 Years | Ruijin Hospital | |
| S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma | NCT04989985 | Locally Advance... Chemotherapy Ef... | Oxaliplatin+S-1 Sinitilimab+oxa... | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer | NCT03007446 | Gastric Cancer | Apatinib Oxaliplatin S-1 | 18 Years - 70 Years | Chinese PLA General Hospital | |
| A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer | NCT05396326 | Gastric Cancer | Oxaliplatin Teysuno Transarterial a... | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer | NCT03192735 | Apatinib Combin... SOX Neoadjuvant The... Locally Advance... | ApatinibMesylat... | 18 Years - 75 Years | Fujian Medical University | |
| An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers | NCT03662659 | Gastric Cancer Cancer of the S... Esophagogastric... | BMS-986213 Nivolumab XELOX FOLFOX SOX | 18 Years - | Bristol-Myers Squibb | |
| A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. | NCT05322577 | Gastric Cancer Gastroesophagea... | Bemarituzumab CAPOX SOX Nivolumab | 18 Years - 100 Years | Amgen | |
| A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer | NCT02817425 | Gastric Cancer | SOX Sequential ... SOX TEGAFOX Sequent... | 18 Years - 75 Years | LanZhou University | |
| SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer | NCT02870153 | Colorectal Neop... | SOX XELOX | 18 Years - 80 Years | The First People's Hospital of Changzhou | |
| Effect and Safety of Adjuvant Huaier Granule Versus Standard Chemotherapy Regimens in Gastric Cancer Patients | NCT05498766 | Gastric Cancer | Huaier granule Oxaliplatin Tegafur, Gimera... Capecitabine | 18 Years - 70 Years | Wuhan Union Hospital, China | |
| A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer | NCT02817425 | Gastric Cancer | SOX Sequential ... SOX TEGAFOX Sequent... | 18 Years - 75 Years | LanZhou University | |
| Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer | NCT03192735 | Apatinib Combin... SOX Neoadjuvant The... Locally Advance... | ApatinibMesylat... | 18 Years - 75 Years | Fujian Medical University | |
| The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer | NCT03007446 | Gastric Cancer | Apatinib Oxaliplatin S-1 | 18 Years - 70 Years | Chinese PLA General Hospital | |
| Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma | NCT01552980 | Gastric Adenoca... | S-1 and Oxalipl... | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery | NCT05468138 | MSI-H PD-1 Immunother... Gastric Cancer Adjuvant Therap... | SOX XELOX Observation PD-1 antibody | 18 Years - 75 Years | Fudan University | |
| Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer | NCT03192735 | Apatinib Combin... SOX Neoadjuvant The... Locally Advance... | ApatinibMesylat... | 18 Years - 75 Years | Fujian Medical University | |
| AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer | NCT06196697 | Gastric Adenoca... Gastroesophagea... | Cadonilimab Ivonescimab XELOX SOX | 18 Years - 75 Years | Harbin Medical University | |
| S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma | NCT04989985 | Locally Advance... Chemotherapy Ef... | Oxaliplatin+S-1 Sinitilimab+oxa... | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer | NCT04062058 | Gastric Cancer Neoadjuvant The... | SIB-IMRT S-1 SOX Surgery | 18 Years - 75 Years | ChineseAMS | |
| Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma | NCT01429961 | Advanced Hepato... | SOX | 18 Years - | Seoul National University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
